Febbre Gialla

2
! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! Indian Ocean Atlantic Ocean RWANDA (Generally Not Recommended) Gao Mao Nema Aleg Niamey Bamako Abeche Agadez Ndjamena Timbuktu El Obeid Khartoum Tidjikdja El Fasher Nouakchott Kidal Arlit SUDAN MALI LIBYA ALGERIA CHAD NIGER EGYPT ANGOLA SAUDI ARABIA ETHIOPIA NIGERIA MAURITANIA ZAMBIA TANZANIA KENYA NAMIBIA SOMALIA YEMEN MOZAMBIQUE BOTSWANA CAMEROON ZIMBABWE GABON GHANA GUINEA UGANDA CENTRAL AFRICAN REPUBLIC SENEGAL BURKINA FASO DEMOCRATIC REPUBLIC OF THE CONGO MADAGASCAR CÔTE D'IVOIRE BENIN WESTERN SAHARA ERITREA MALAWI LIBERIA TOGO REPUBLIC OF THE CONGO SOUTH AFRICA SIERRA LEONE BURUNDI DJIBOUTI GUINEA-BISSAU EQUATORIAL GUINEA THE GAMBIA COMOROS CAPE VERDE MAYOTTE SÃO TOMÉ AND PRÍNCIPE SEYCHELLES * Yellow fever (YF) vaccination is generally not recommended in areas where there is low potential for YF virus exposure. However, vaccination might be considered for a small subset of travelers to these areas who are at increased risk for exposure to YF virus because of prolonged travel, heavy exposure to mosquitoes, or inability to avoid mosquito bites. Consideration for vaccination of any traveler must take into account the traveler’s risk of being infected with YF virus, country entry requirements, and individual risk factors for serious vaccine-associated adverse events (e.g., age, immune status). Yellow Fever Vaccination Generally Not Recommended* Not Recommended Recommended

description

febbre gialla

Transcript of Febbre Gialla

Page 1: Febbre Gialla

!

!

!

!

!!

!!

!

!

!

!

!

!

!

!!

I n d i a nO c e a n

A t l a n t i cO c e a n

RWANDA(Generally Not Recommended )

Gao

Mao

NemaAleg

NiameyBamako

Abeche

Agadez

Ndjamena

Timbuktu

El Obeid

Khartoum

Tidj ikdja

El Fasher

Nouakchot t Kidal Ar l i t

SUDAN

MALI

LIBYAALGERIA

CHADNIGER

EGYPT

ANGOLA

SAUDI ARABIA

ETHIOPIA

NIGERIA

MAURITANIA

ZAMBIA

TANZANIA

KENYA

NAMIBIA

SOMALIA

YEMEN

MOZAMBIQUE

BOTSWANA

CAMEROON

ZIMBABWE

GABON

GHANA

GUINEA

UGANDA

CENTRALAFRICAN REPUBLIC

SENEGAL

BURKINA FASO

DEMOCRATIC REPUBLICOF THE CONGO

MADAGASCAR

CÔTED'IVOIRE

BENIN

WESTERN SAHARA

ERITREA

MALAWI

LIBERIATOGO

REPUBLIC OF THE CONGO

SOUTHAFRICA

SIERRA LEONE

BURUNDI

DJIBOUTIGUINEA-BISSAU

EQUATORIAL GUINEA

THE GAMBIA

COMOROS

CAPE VERDE

MAYOTTE

SÃO TOMÉ AND PRÍNCIPE

SEYCHELLES

!

!

!

!

!!

!!

!

!

!

!

!

!

!

!!

I n d i a nO c e a n

A t l a n t i cO c e a n

RWANDA(Generally Not Recommended )

Gao

Mao

NemaAleg

NiameyBamako

Abeche

Agadez

Ndjamena

Timbuktu

El Obeid

Khartoum

Tidj ikdja

El Fasher

Nouakchot t Kidal Ar l i t

SUDAN

MALI

LIBYAALGERIA

CHADNIGER

EGYPT

ANGOLA

SAUDI ARABIA

ETHIOPIA

NIGERIA

MAURITANIA

ZAMBIA

TANZANIA

KENYA

NAMIBIA

SOMALIA

YEMEN

MOZAMBIQUE

BOTSWANA

CAMEROON

ZIMBABWE

GABON

GHANA

GUINEA

UGANDA

CENTRALAFRICAN REPUBLIC

SENEGAL

BURKINA FASO

DEMOCRATIC REPUBLICOF THE CONGO

MADAGASCAR

CÔTED'IVOIRE

BENIN

WESTERN SAHARA

ERITREA

MALAWI

LIBERIATOGO

REPUBLIC OF THE CONGO

SOUTHAFRICA

SIERRA LEONE

BURUNDI

DJIBOUTIGUINEA-BISSAU

EQUATORIAL GUINEA

THE GAMBIA

COMOROS

CAPE VERDE

MAYOTTE

SÃO TOMÉ AND PRÍNCIPE

SEYCHELLES

* Yellow fever (YF) vaccination is generally not recommended in areas where there is lowpotential for YF virus exposure. However, vaccination might be considered for a smallsubset of travelers to these areas who are at increased risk for exposure to YF virus becauseof prolonged travel, heavy exposure to mosquitoes, or inability to avoid mosquito bites. Consideration for vaccination of any traveler must take into account the traveler’s riskof being infected with YF virus, country entry requirements, and individual risk factors forserious vaccine-associated adverse events (e.g., age, immune status).

Yellow Fever Vaccination

General ly Not Recommended*Not Recommended

Recommended

Page 2: Febbre Gialla

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

Igua ssu Fa l ls

!(

Panama Cana l Zone A t l a n t i c

O c e a n

Re siste nc ia

Puyo

Hor izonteBe lo

Ri o de Ja ne iro

São Pa ulo

San ta Cruz

BRAZ IL

ARGENT INA

PERU

BOLIV IA

CHILE

COLOMBIA

VENEZUELA

PARAGUAY

ECUADOR

GUYANA

URUGUAY

SURINAME

PANAMA

FRENCH GUIANA

Falkland Is lands

TR INIDAD AND TOBAGOCaraca s

Matur in

Panam a C i ty

Qui to

Forta lez a

Cuzc o

La Pa zSucre

Bra sí l i a

Lim a

Iqui tos

Sal t a

Ta r i ja

Ara c aj uHu án uc o

Ri ob am ba

Cha cha poya sRe c i fe

Man au s

Salv ador

Cali BogotáMedellín

CartagenaSanta Marta

P a c i f i c

O c e a n

*Yellow Fever (YF) vaccination is generally not recommended in areaswhere there is low potential for YF virus exposure. Consideration forvaccination of travelers visiting these areas must weigh potential forincreased exposure to YF virus (e.g. prolonged travel, heavy exposure to mosquitoes, inability to avoid mosquito bites) against individual riskfactors for vaccine-associated adverse events (e.g. age, immune status).

Yellow Fever Vaccination

General ly Not Recommended*Not Recommended

Recommended

* Yellow fever (YF) vaccination is generally not recommended in areas where there is low potentialfor YF virus exposure. However, vaccination might be considered for a small subset of travelersto these areas who are at increased risk for exposure to YF virus because of prolonged travel, heavyexposure to mosquitoes, or inability to avoid mosquito bites. Consideration for vaccination ofany traveler must take into account the traveler’s risk of being infected with YF virus, countryentry requirements, and individual risk factors for serious vaccine-associatedadverse events (e.g., age, immune status).